1. Time to viral suppression is not related to achievement of SVR12 in HCV GT1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. Issue 4 (9th December 2016) Authors: Alqahtani, S.; Ozaras, R.; Isakov, V.; Wyles, D.; Ferenci, P.; Feld, J. J.; Calinas, F.; Gschwantler, M.; Gane, E.; Crawford, D.; Jacobson, I. M.; Dumas, E. O.; King, M.; Sulkowski, M. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 4(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗